At Maxkosh India, we are dedicated to delivering a wide and diverse portfolio of high-quality medicines that address both chronic and acute healthcare needs. Our product range includes generics, branded formulations, speciality products, technologically advanced medicines, over-the-counter (OTC) solutions, Active Pharmaceutical Ingredients (APIs), and intermediates. With a strong presence across India, we focus on ensuring accessibility and affordability while continuously expanding our offerings to meet evolving patient needs.
Maxkosh India is committed to building a strong pipeline of speciality medicines designed to improve patient outcomes. Our primary focus areas include dermatology, ophthalmology, oncology, and critical care segments. By investing in research, technology, and strategic collaborations, we aim to address unmet medical needs and provide differentiated treatment options. Our approach spans the entire value chain, from early-stage product development to market-ready formulations.
We provide reliable, affordable, and effective generic medicines that meet international quality standards. Our portfolio covers a wide spectrum of therapeutic areas, including cardiology, neurology, orthopaedics, diabetology, gastroenterology, respiratory, nephrology, gynaecology, dermatology, psychiatry, oncology, and nutritionals. With dosage forms ranging from tablets, capsules, and injectables to ointments, inhalers, and syrups, we ensure comprehensive treatment solutions for healthcare professionals and patients.
Maxkosh India also offers a growing range of OTC and consumer healthcare products designed for everyday wellness. From pain relief and digestive care to nutritional supplements and common cold remedies, our OTC portfolio is crafted to provide safe, effective, and easily accessible healthcare solutions to households.
Through our Contract Research and Manufacturing Services (CRAMS), we partner with pharmaceutical companies to deliver reliable custom synthesis, bulk actives, and finished formulations. This strengthens our position as a trusted partner in the healthcare value chain.
Our API division plays a crucial role in enabling vertically integrated manufacturing. Maxkosh India produces a wide range of APIs and intermediates that support our own formulations as well as serve domestic and global partners. With expertise in complex APIs such as oncology, peptides, steroids, and controlled substances, we ensure stringent quality standards and regulatory compliance.
Tablet
Short product description...
Syrup
Short product description...
Tablets
Short product description...